162. Pemphigoid
70 clinical trials,   117 drugs   (DrugBank: 46 drugs),   30 drug target genes,   128 drug target pathways

Searched query = "Pemphigoid", "Epidermolysis bullosa acquisita"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03286582
(ClinicalTrials.gov)
September 5, 201714/9/2017A Proof-of-Concept Study of Topical AC-203 in Patients With Bullous PemphigoidA Randomized, Open-Label, Controlled Trial of Topical AC-203 in Subjects With Bullous PemphigoidBullous PemphigoidDrug: AC-203 1% Topical Ointment;Drug: Clobetasol 0.05% Topical OintmentTWi Biotechnology, Inc.NULLTerminated20 Years90 YearsAll10Phase 2Taiwan